2m 2m 2m 2m 2m 2m 2m
AN2 THERAPEUTIC (ANTX)
NASDAQ
$4.47+$0.13 (+3.12%)
Price as of Nov 11, 2026 7:55 PM EST- $163.4MMarket Cap
- 260.83%1-Year Change
- BiotechnologyIndustry
AN2 THERAPEUTIC (ANTX)
$4.47+$0.13 (+3.12%)
Earnings Score
Valuation | ANTX | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | N/A | ||
Low Earnings Volatility | N/A |
Momentum Score
Valuation | ANTX | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -27.24% | ||
12-Month Momentum | 264.41% | ||
3-Month Risk Adjusted Momentum | -111.66% | ||
12-Month Risk Adjusted Momentum | 202.42% |
True Yield
Valuation | ANTX | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | ANTX | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | -0 |